Baxdrostat
AstraZeneca
[]
in adults with treatment-resistant hypertension, aldosterone synthase inhibition with #baxdrostat at a dose of 1 mg or 2 mg daily led to significantly greater reductions in systolic blood pressure over 12 weeks than placebo.#acc23 
Cardiology Senior resident | @CardioDir 🫀| Sincerely yours, Forevermore🖤